BSECompany Update9 Aug 2026 · 9 Aug 2026, 09:32 am
Gland Pharma announces strategic CDMO partnership with a Global Pharmaceutical Company
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveM&A
Gland Pharma Ltd announced a strategic partnership with a global pharmaceutical company for manufacturing and supply of sterile injectable products. The partnership is expected to provide strong long-term business support and improve the company's product life cycle, with a focus on development, process, quality, and regulatory support.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release